Stanford University
Showing 201-300 of 505 Results
-
Christian Kunder
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main interest is in understanding the biology of human neoplasms, using traditional histopathology, molecular genetic techniques, and other modalities. In particular, I am interested in soft tissue and genitourinary neoplasms, especially prostate cancer.
I am also interested in the classification and nomenclature of neoplasms and in practical research that helps us refine these, using a variety of techniques but still principally guided by histopathology.
I also work on developing next generation sequencing-based tests for genotyping tumors and in expanding the scope of this testing with the goal of identifying patients eligible for novel targeting therapies. -
Masako Lien Petty Le-Maciukiewicz, MD, MSc
Affiliate, Pathology Ops Business Office
BioMy current research focuses neurodegenerative and ocular diseases, with an added focus on the unfolded protein response, specifically the PERK pathway. Through my work, I investigate the cellular mechanisms underlying diseases like Alzheimer's and advanced tauopathies, with an emphasis on endoplasmic reticulum (ER) stress.
As I continue to deepen my understanding of disease pathology, I am also pursuing a residency in pathology (ECFMG-Certified, AAMC: 14765627), with a current interest in neuropathology and forensic pathology. Alongside my primary research, I have been involved in a forensic unidentified persons project, applying my skills from my previous graduate studies in forensic science and extensive autopsy experience. Here I further explore my passion for understanding disease processes and the human body through both clinical and investigative perspectives, fueled by empathy and compassion.
Additionally, I volunteer as a crisis counselor and enjoy activities such as traveling and learning languages, Toastmasters, and escape rooms. -
Maayan Levy
Assistant Professor of Pathology
Current Research and Scholarly InterestsThe Levy Lab studies how microbiome-brain interactions influence metabolism, behavior, and disease. By investigating how microbial signals affect neural circuits, we explore mechanisms underlying obesity, diabetes, and psychiatric conditions. The lab seeks to uncover new therapeutic targets using advanced neuroscience tools like optogenetics and imaging. Our research aims to improve understanding of how microbiome imbalances contribute to disease and how restoring balance can promote health.
-
Joseph (Joe) Lipsick
Professor of Pathology and of Genetics
Current Research and Scholarly InterestsFunction and evolution of the Myb oncogene family; function and evolution of E2F transcriptional regulators and RB tumor suppressors; epigenetic regulation of chromatin and chromosomes; cancer genetics.
-
Jonathan T.C. Liu
Professor of Pathology and Professor, by courtesy, of Bioengineering
Current Research and Scholarly InterestsBiomedical optics
In vivo microscopy
Slide-free pathology
Three-dimensional microscopy
3D pathology
Optical biopsy
Image-guided surgery
Early detection
Artificial intelligence
Machine learning
Deep learning
Computational analysis
Computational pathology
Virtual staining
Molecular imaging -
Amy Lo
Adjunct Clinical Associate Professor, Pathology
BioDr. Amy Lo is a pathologist with board certification in anatomic pathology, clinical pathology and molecular genetic pathology. She completed her MD and MS at the University of Illinois at Chicago and her residency in both anatomic and clinical pathology at Northwestern University. She then joined the faculty at Northwestern University as a Clinical Instructor and Advanced Gastrointestinal/Surgical Pathology Fellow. Amy then completed a molecular genetic pathology fellowship at Stanford University.
In 2016, Amy joined Genentech as research pathology scientist supporting drug research and development with a focus in oncology and individualized drug development.
Additionally, Amy continues clinical work as an Adjunct Clinical Associate Professor in pathology at Stanford University and Lucille Packard’s Children’s Hospital. -
Avinash Londhe
Postdoctoral Scholar, Pathology
BioDr. Avinash Londhe is a postdoctoral researcher in Dr. Katrin Svensson’s lab in the Department of Pathology at Stanford University, where he investigates the complex mechanisms linking cancer, metabolism, and obesity. His research focuses on understanding how orphan peptide hormones regulate metabolic pathways and identifying novel receptor-peptide interactions. Driven by a passion for translational science, Dr. Londhe is committed to translating fundamental discoveries into real-world solutions that improve patient outcomes.
During his doctoral training in Dr. Benoit Boivin’s lab at SUNY Polytechnic Institute, Dr. Londhe gained in-depth expertise in molecular mechanisms underlying metabolic disorders and cancer. His work contributed to the development of therapeutic strategies aimed at metabolic dysfunction. In addition to research, he excelled at managing laboratory operations and mentoring both graduate and undergraduate students, fostering a dynamic and collaborative research environment.
Currently, Dr. Londhe is broadening his research toolkit by integrating bioinformatics, molecular biology, and biophysical techniques into his experimental approaches. His goal is to address critical challenges in cancer metabolism and metabolic diseases through innovative research.
Dr. Londhe aspires to secure a faculty position at a leading university, where he can advance impactful research, mentor emerging scientists, and continue driving scientific innovation. -
Jonathan Z. Long
Associate Professor of Pathology
BioDr. Jonathan Long is an Associate Professor of Pathology and an Institute Scholar of Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health). His laboratory studies the molecular mechanisms of mammalian energy homeostasis. Dr. Long is the recipient of the Alfred P. Sloan Research Fellowship in Chemistry, the Breakthrough Sciences Award from the Ono Pharma Foundation, and the NIDDK Catalyst Award. Prior to arriving to Stanford, Dr. Long completed his Ph.D. in Chemistry at Scripps Research and his postdoctoral work at Harvard Medical School.
-
Teri A Longacre
Richard L. Kempson, MD, Professor in Surgical Pathology
Current Research and Scholarly InterestsGynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.
-
Alarice Cheng-Yi Lowe
Associate Professor of Pathology
BioDr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of new technology to improve clinical and molecular diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly InterestsWe are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimers and Parkinsons diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Emma Lundberg
Associate Professor of Bioengineering and of Pathology
BioDr. Emma Lundberg is an Associate Professor of Bioengineering and Pathology at Stanford University and serves at the Director of the Cell Atlas of the Human Protein Atlas initiative in Sweden, where she is also Professor at KTH Royal Institute of Technology. At the intersection of bioimaging, proteomics, and artificial intelligence, her research aims to define the spatiotemporal organization of the human proteome at both cellular and subcellular level. Dr. Lundberg aims to develop integrated models of human cells to elucidate how variations in protein localization patterns influence cellular function, ultimately enabling the simulation of cell behavior and a systems-level understanding of how biological information is spatially encoded. The Lundberg Lab is responsible for creating the Subcellular Atlas of the Human Protein Atlas database (https://www.proteinatlas.org/). Dr. Lundberg is dedicated to building virtual cell models to simulate cell behavior, and is passionate about engaging the public in her work through citizen science games and computational challenges.
Dr. Lundberg holds a Master’s degree in Bioengineering and a PhD in Biotechnology from KTH Royal Institute of Technology in Sweden. She has served as Secretary General of the Human Proteome Organization, and is actively involved in advisory roles for numerous open-access databases and cell mapping efforts such as the CZI AI Virtual Cell, Human Cell Atlas consortium, UniProt db, Reactome db, Human Proteome Project and various pharma and biotech companies. As a token of her leadership skills and advocate for open science, she was twice recognized as top 10 under 40 for future leaders in biopharma and omics. -
Ruben Y. Luo
Assistant Professor of Pathology
Current Research and Scholarly InterestsApply top-down mass spectrometry and label-free immunoassay to the study and utilization of biomarker proteoforms in clinical diagnosis.
-
Amirreza Mahbod
Affiliate, Pathology Clinical Faculty PTAs
BioI am an Associate Professor at Danube Private University (Austria), affiliated with the Research Center for Medical Image Analysis and Artificial Intelligence. I am also a Fulbright Visiting Scholar at the Department of Pathology and the Center for Artificial Intelligence in Medicine & Imaging at Stanford University, hosted by Prof. Jeanne Shen.
My research focuses on deep learning in computational pathology, multimodal medical data integration, and the development and adaptation of medical foundation models for healthcare applications.
Additional Links:
Linkedin: www.linkedin.com/in/amirreza-mahbod
Google Scholar: https://scholar.google.com/citations?user=yJgcjbMAAAAJ&hl=en -
Magdalena Matusiak
Instructor, Pathology
Current Research and Scholarly InterestsMy research focuses on revealing clinically relevant prognostic markers associated with myeloid cell biology.
-
Joshua Menke
Clinical Associate Professor, Pathology
BioDr. Joshua Menke completed his hematopathology fellowship at Stanford and a cytopathology fellowship at the University of California, San Francisco (UCSF). His clinical and research interests lie at the intersection of hematopathology, cytopathology, and advanced single-cell and cell-free diagnostic techniques. As the Associate Section Director of Clinical Flow Cytometry at Stanford, Dr. Menke is developing and validating new minimal residual disease assays for detecting low levels of myeloid and lymphoid neoplasms in the post-treatment setting, as well as multiple other 12-color flow assays with the latest markers for routine phenotyping.
Dr. Menke is the recipient of the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Scientists and the Laurence J. Marton Award for Excellence in Research from UCSF for his translational work on CALR mutations at the UCSF Molecular Diagnostics Laboratory. Dr. Menke is a founding member of the Cytology-Hematopathology Interinstitutional Collaboration (CHIC), which aims to study the performance of cytology samples in diagnosing lymphoma across large datasets from five academic institutions. He currently chairs this group, leading large clinical research studies. -
Sara Michie
Professor of Pathology (Research), Emerita
Current Research and Scholarly InterestsLymphocyte/endothelial cell adhesion mechanisms involved in lymphocyte migration to sites of inflammation; regulation of expression of endothelial cell adhesion molecules.
-
Michelle M. Miranda Vélez
Affiliate, Pathology Research Faculty PTAs
BioMichelle Miranda (she/her) is a postdoctoral scholar in the Dodd Lab in the Pathology Department. Her research interest lies in bridging science and medicine by implementing core chemistry to study and improve human health.
-
Paul Salomon Mischel
Fortinet Founders Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research bridges cancer genetics, signal transduction and cellular metabolism as we aim to understand the molecular mechanisms that drive cancer development, progression, and drug resistance. We have made a series of discoveries that have identified a central role for ecDNA (extrachromosomal DNA) in cancer development, progression, accelerated tumor evolution and drug resistance.
-
Maneesh Kumar Misra
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy research goal is to utilize the cutting edge of stat of art histocompatibility testing to better understand the humoral and cellular responses in clinical transplantation, and to translate this knowledge into improved treatment, and transplant outcome.
-
Michelle Monje
Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.
-
Stephen B. Montgomery
Stanford Medicine Professor of Pathology, Professor of Genetics and of Biomedical Data Science and, by courtesy, of Computer Science
Current Research and Scholarly InterestsWe focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/
-
Thomas Montine, MD, PhD
Stanford Medicine Professor of Pathology
BioDr. Montine is the Stanford Medicine Endowed Professor, Chair of Stanford Pathology Department, and member of the National Academy of Medicine. He received his education and medical training at Columbia University, McGill University, and Duke University, and was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology at the University of Washington where he was Director of the University of Washington Alzheimer’s Disease Research Center, one of the original 10 Centers in the US, and founding Director of the Pacific Udall Center, a NINDS-funded Center of Excellence for Parkinson’s Disease Research. Dr. Montine was Chair of the Department of Pathology at the University of Washington from 2010 to 2016 when he was appointed Chair of the Department of Pathology at Stanford University where he is the Stanford Medicine Endowed Professor.
The focus of the Montine Laboratory is on the structural and molecular bases of cognitive impairment. The Montine Laboratory addresses this prevalent, unmet medical need through a combination of neuropathology, biomarkers for detection and progression of early disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and then develop novel approaches to neuroprotection. Our current approaches include small molecule precision therapeutics and cell replacement strategies for brain. -
Solene Moulin
Postdoctoral Scholar, Pathology
BioI am a very curious person who likes to understand how things work and I love to contribute to new discoveries that will help to cope with tomorrow’s challenges. After my studies at the Ecole Normale Supérieure Ulm, I got specialized in plant science. I am interested in this research field because plants are critical for environment as well as for food and bio-energy production. In 2016, I joined CEA Cadarache for my PhD which led me to participate in a research program on hydrocarbon synthesis in algae. I really liked this project which was focusing on both reaching a bio-based production of hydrocarbons for fuel production and deciphering of the hydrocarbon synthesis pathway in algae. I have been leading research to assess the occurrence of this pathway in the different types of eukaryotic algae, its evolutionary history and its relevance for algal physiology. I am now going to study another evolutionary history that has led to a symbiosis between a diatom and a N-fixing cyanobacteria, the latest being on its way to become an organelle. Understanding the physiological relationship between the diatom and the cyanobacteria will help understanding nitrogen cycle and could lead to major innovations in farming.
-
Saisindhu Narala, MD, MAS
Clinical Assistant Professor, Dermatology
Clinical Assistant Professor (By courtesy), PathologyBioDr. Narala completed her dermatology residency at the University of Texas at Houston and MD Anderson Cancer Center. She then completed a fellowship in dermatopathology at Stanford. Her clinical interests include general medical dermatology, dermatology in skin of color, and pigmentary disorders. She also has an interest in medical education.
-
Yasodha Natkunam, M.D., Ph.D
Ronald F. Dorfman, MBBch, FRCPath Professor of Hematopathology
Current Research and Scholarly InterestsMy research interests focus on the identification and characterization of markers of diagnostic and prognostic importance in hematolymphoid neoplasia.
-
Roberto Novoa, MD
Clinical Professor, Pathology
Clinical Professor, DermatologyCurrent Research and Scholarly InterestsMy research interests include the medical applications of artificial intelligence, cutaneous lymphoma, and the side effects of targeted therapies. I have served as the lead dermatologist in our ongoing effort to develop AI-augmented classification of skin lesions. We are in the process of establishing one of the first prospective studies examining the performance of a deep learning algorithm in real-world patients.
-
Jean Oak
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsDr. Oak received her MD and PhD from University of California, Irvine, and completed her anatomic pathology and clinical pathology residency, hematopathology fellowship, and transfusion medicine fellowship at Stanford University. Her research and clinical interests include clinical assay development for tumor immunophenotyping, lymphocyte subset monitoring, and immunotherapy target antigen assessment in a variety of hematologic and immunologic disorders. As director of a clinical flow cytometry laboratory, she oversees the design, validation, and implementation of various immunophenotyping assays in addition to ensuring quality assurance and regulatory compliance for CLIA certification.
-
Derick Okwan
Assistant Professor of Pathology
Current Research and Scholarly InterestsBroadly, the Okwan lab’s primary interest is to understand how and why the immune system contributes to nearly all chronic diseases. The immune system of the modern human has evolved from a history of stress to the species: famines, continual bouts of lethal pandemics, as well as major climate/environmental and migratory changes that exposed the immune system to novel threats. At the forefront of these challenges are innate immune cells, particularly neutrophils, the most abundant leukocytes. For the first time in human history – at least in the western world- we live in an era of abundance. The Okwan lab is interested in understanding how this traumatic history creates a functional mismatch for the neutrophil, which we believe underpins their roles in chronic diseases of the modern era: cancer, cardiovascular disease, neurodegeneration, and autoimmune disorders. Rather than wholesale depletion of neutrophils and innate immune cells, we seek to identify novel approaches to leverage these cells to combat various diseases.
